研究成果


第 1 到 180 筆結果，共 180 筆。

公開日期標題作者來源出版物scopusWOS全文
12024Tenofovir versus entecavir on recurrence and mortality of hepatitis B virus-related hepatocellular carcinoma after curative therapyChang, Kai-Chun; TUNG-HUNG SU ; SIH-HAN LIAO ; TAI-CHUNG TSENG ; SHANG-CHIN HUANG ; SHIH-JER HSU ; CHUN-MING HONG ; CHEN-HUA LIU ; HUNG-CHIH YANG ; CHUN-JEN LIU ; JIA-HORNG KAO Journal of the Formosan Medical Association = Taiwan yi zhi
22024Tenofovir versus entecavir on recurrence and mortality of hepatitis B virus-related hepatocellular carcinoma after curative therapyChang, Kai-Chun; TUNG-HUNG SU ; SIH-HAN LIAO ; TAI-CHUNG TSENG ; SHANG-CHIN HUANG ; SHIH-JER HSU ; CHUN-MING HONG ; CHEN-HUA LIU ; Yang, Hung-Chih; Liu, Chun-Jen; Kao, Jia-HorngJournal of the Formosan Medical Association = Taiwan yi zhi0
32024HBcrAg-based risk score performs better than the HBV DNA-based scores for HCC prediction in grey zone patients who are HBeAg-negativeTAI-CHUNG TSENG ; Hosaka, Tetsuya; CHUN-JEN LIU ; Suzuki, Fumitaka; Chiang, Chieh; CHUN-MING HONG ; Kumada, Hiromitsu; Yang, Wan-Ting; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHEN-HUA LIU ; PEI-JER CHEN ; JIA-HORNG KAO JHEP reports : innovation in hepatology
42024Metabolic Dysfunction-Associated Steatotic Liver Disease Facilitates Hepatitis B Surface Antigen Seroclearance and SeroconversionSHANG-CHIN HUANG ; TUNG-HUNG SU ; TAI-CHUNG TSENG ; CHI-LING CHEN ; SHIH-JER HSU ; CHEN-HUA LIU ; SIH-HAN LIAO ; CHUN-MING HONG ; Lan, Ting Yuan; HUNG-CHIH YANG ; CHUN-JEN LIU ; PEI-JER CHEN ; JIA-HORNG KAO Clinical Gastroenterology and Hepatology2
52023Optimizing Survival Benefit by Surgical Resection by the Seven-Eleven Criteria in Barcelona Clinic Liver Cancer Stage A/B Hepatocellular Carcinoma beyond the Milan CriteriaHuang, Chian Tzu; Chu, Yu Long; TUNG-HUNG SU ; SHANG-CHIN HUANG ; TAI-CHUNG TSENG ; SHIH-JER HSU ; SIH-HAN LIAO ; CHUN-MING HONG ; CHEN-HUA LIU ; HUNG-CHIH YANG ; CHUN-JEN LIU ; PEI-JER CHEN ; JIA-HORNG KAO Liver Cancer
62023Editorial: Noninvasive tests for metabolic dysfunction-associated steatotic liver disease: A refinement of the Nash-FibroTest for type 2 diabetes mellitusCHEN-HUA LIU Alimentary pharmacology & therapeutics
72023Toward the hepatitis C virus elimination in Asia: The policy forum from the 2023 Asian Pacific Association of the Study of the Liver (APASL)CHEN-HUA LIU ; Lin, Han-Chieh; JIA-HORNG KAO Journal of the Formosan Medical Association = Taiwan yi zhi00
82023Acute hepatitis C virus infection: clinical update and remaining challengesCHEN-HUA LIU ; JIA-HORNG KAO Clinical and molecular hepatology65
92023Serum cytokine profiles predict outcomes of chronic hepatitis B patients discontinuing entecavir or tenofovir therapyLin, Meng-Ju; TUNG-HUNG SU ; CHUN-JEN LIU ; HUNG-CHIH YANG ; CHI-LING CHEN ; JYH-MING LIOU ; TAI-CHUNG TSENG ; CHEN-HUA LIU ; CHUN-MING HONG ; PEI-JER CHEN ; JIA-HORNG KAO Journal of the Formosan Medical Association = Taiwan yi zhi21
102023Serial increase and high alpha-fetoprotein levels predict the development of hepatocellular carcinoma in 6 monthsTUNG-HUNG SU ; Chang, Shan-Han; CHI-LING CHEN ; SIH-HAN LIAO ; TAI-CHUNG TSENG ; SHIH-JER HSU ; CHUN-MING HONG ; CHEN-HUA LIU ; HUNG-CHIH YANG ; CHUN-JEN LIU ; PEI-JER CHEN ; JIA-HORNG KAO Hepatology research : the official journal of the Japan Society of Hepatology10
112023Distinct effects of hepatic steatosis and metabolic dysfunction on the risk of hepatocellular carcinoma in chronic hepatitis BSHANG-CHIN HUANG ; TUNG-HUNG SU ; TAI-CHUNG TSENG ; CHI-LING CHEN ; SHIH-JER HSU ; SIH-HAN LIAO ; CHUN-MING HONG ; CHEN-HUA LIU ; Lan, Ting-Yuan; HUNG-CHIH YANG ; CHUN-JEN LIU ; PEI-JER CHEN ; JIA-HORNG KAO Hepatology international52
122023Pre-operative gamma-glutamyl transferase levels predict outcomes in hepatitis B-related hepatocellular carcinoma after curative resectionTUNG-HUNG SU ; SHANG-CHIN HUANG ; CHI-LING CHEN ; SHIH-JER HSU ; SIH-HAN LIAO ; CHUN-MING HONG ; TAI-CHUNG TSENG ; CHEN-HUA LIU ; HUNG-CHIH YANG ; YAO-MING WU ; CHUN-JEN LIU ; PEI-JER CHEN ; JIA-HORNG KAO Journal of the Formosan Medical Association = Taiwan yi zhi20
132023Low Hepatitis B Core-Related Antigen Levels Correlate Higher Spontaneous Seroclearance of Hepatitis B Surface Antigen in Chronic Hepatitis B Patients With High Hepatitis B Surface Antigen LevelsTAI-CHUNG TSENG ; Chiang, Chieh; CHUN-JEN LIU ; CHUN-MING HONG ; TUNG-HUNG SU ; HUNG-CHIH YANG ; Yang, Wan-Ting; CHEN-HUA LIU ; PEI-JER CHEN ; JIA-HORNG KAO Gastroenterology44
142023Long-term durability of sustained virologic response for hepatitis C virus infection in solid organ transplant recipients receiving direct-acting antiviralsCHEN-HUA LIU ; YIH-SHARNG CHEN ; MENG-KUN TSAI ; Wang, Sheoi-Shen; CHIH-YUAN LEE ; Tsao, Chuan-I; CHUN-JEN LIU ; TUNG-HUNG SU ; TAI-CHUNG TSENG ; SHANG-CHIN HUANG ; Wu, Jo-Hsuan; PEI-JER CHEN ; JIA-HORNG KAO Journal of the Formosan Medical Association = Taiwan yi zhi00
152023Splenic Arterial Pulsatility Index to Predict Hepatic Fibrosis in Hemodialysis Patients with Chronic Hepatitis C Virus InfectionCHEN-HUA LIU ; YU-JEN FANG ; CHUN-JEN LIU ; TUNG-HUNG SU ; SHANG-CHIN HUANG ; TAI-CHUNG TSENG ; Wu, Jo-Hsuan; PEI-JER CHEN ; JIA-HORNG KAO Journal of clinical medicine00
162023Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in TaiwanTsai, Pei-Chien; Kuo, Hsing-Tao; Hung, Chao-Hung; Tseng, Kuo-Chih; Lai, Hsueh-Chou; Peng, Cheng-Yuan; Wang, Jing-Houng; Chen, Jyh-Jou; Lee, Pei-Lun; Chien, Rong-Nan; Yang, Chi-Chieh; Lo, Gin-Ho; JIA-HORNG KAO ; CHUN-JEN LIU ; CHEN-HUA LIU ; Yan, Sheng-Lei; Bair, Ming-Jong; Lin, Chun-Yen; Su, Wei-Wen; Chu, Cheng-Hsin; Chen, Chih-Jen; Tung, Shui-Yi; Tai, Chi-Ming; Lin, Chih-Wen; Lo, Ching-Chu; Cheng, Pin-Nan; Chiu, Yen-Cheng; Wang, Chia-Chi; Cheng, Jin-Shiung; Tsai, Wei-Lun; Lin, Han-Chieh; Huang, Yi-Hsiang; Yeh, Ming-Lun; Huang, Chung-Feng; Hsieh, Meng-Hsuan; Huang, Jee-Fu; Dai, Chia-Yen; Chung, Wan-Long; Chen, Chi-Yi; Yu, Ming-LungJournal of hepatology168
172023Sofosbuvir/velpatasvir/voxilaprevir for patients with chronic hepatitis C virus infection previously treated with NS5A direct-acting antivirals: a real-world multicenter cohort in TaiwanCHEN-HUA LIU ; Peng, Cheng-Yuan; CHUN-JEN LIU ; Chen, Chi-Yi; Lo, Ching-Chu; Tseng, Kuo-Chih; Su, Pei-Yuan; Kao, Wei-Yu; Tsai, Ming-Chang; Tung, Hung-Da; Cheng, Hao-Tsai; Lee, Fu-Jen; Huang, Chia-Sheng; Huang, Ke-Jhang; Shih, Yu-Lueng; Yang, Sheng-Shun; Wu, Jo-Hsuan; Lai, Hsueh-Chou; YU-JEN FANG ; Chen, Po-Yueh; Hwang, Jow-Jyh; Tseng, Chi-Wei; Su, Wei-Wen; Chang, Chun-Chao; Lee, Pei-Lun; Chen, Jyh-Jou; Chang, Chi-Yang; Hsieh, Tsai-Yuan; Chang, Chung-Hsin; Huang, Yi-Jie; JIA-HORNG KAO Hepatology international54
182023Long-term Evolution of Estimated Glomerular Filtration Rate in Patients With Antiviral Treatment for Hepatitis C Virus InfectionCHEN-HUA LIU ; JOU-WEI LIN ; CHUN-JEN LIU ; TUNG-HUNG SU ; Wu, Jo-Hsuan; TAI-CHUNG TSENG ; PEI-JER CHEN ; JIA-HORNG KAO Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association78
192022Serum Mac-2 Binding Protein Glycosylation Isomer to Predict the Severity of Hepatic Fibrosis in Patients with Hepatitis C Virus InfectionCHEN-HUA LIU ; CHUN-JEN LIU ; TUNG-HUNG SU ; SHANG-CHIN HUANG ; TAI-CHUNG TSENG ; Wu, Jo-Hsuan; PEI-JER CHEN ; JIA-HORNG KAO Diagnostics (Basel, Switzerland)11
202022Noninvasive Diagnosis of Hepatic Fibrosis in Hemodialysis Patients with Hepatitis C Virus InfectionCHEN-HUA LIU ; JIA-HORNG KAO Diagnostics (Basel, Switzerland)11
212022Prothrombin induced by vitamin K absence or antagonist-II (PIVKA-II) predicts complete responses of transarterial chemoembolization for hepatocellular carcinomaWang, Sung-Yin; TUNG-HUNG SU ; BANG-BIN CHEN ; CHUN-JEN LIU ; CHEN-HUA LIU ; HUNG-CHIH YANG ; TAI-CHUNG TSENG ; PEI-JER CHEN ; JIA-HORNG KAO Journal of the Formosan Medical Association = Taiwan yi zhi44
222022Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR StudyCHEN-HUA LIU ; HSIN-YUN SUN ; Peng, Cheng-Yuan; SZU-MIN HSIEH ; Yang, Sheng-Shun; Kao, Wei-Yu; Shih, Yu-Lueng; Lin, Chih-Lin; CHUN-JEN LIU ; WANG-HUEI SHENG ; Lo, Yi-Chun; Liu, Wen-Chun; Wu, Jo-Hsuan; TUNG-HUNG SU ; TAI-CHUNG TSENG ; PEI-JER CHEN ; CHIEN-CHING HUNG ; JIA-HORNG KAO Open forum infectious diseases97
232022Hepatitis B Core-Related Antigen Stratifies the Risk of Liver Cancer in HBeAg-Negative Patients With Indeterminate PhaseTAI-CHUNG TSENG ; Hosaka, Tetsuya; CHUN-JEN LIU ; Suzuki, Fumitaka; CHUN-MING HONG ; Kumada, Hiromitsu; Yang, Wan-Ting; Hsu, Chen-Yang; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHEN-HUA LIU ; PEI-JER CHEN ; HSIU-HSI CHEN ; JIA-HORNG KAO The American journal of gastroenterology1412
242022Serum cytokine/chemokine profiles predict hepatitis B reactivation in HBV/HCV co-infected subjects receiving direct-acting antiviral agentsSHANG-CHIN HUANG ; Cheng, Pin-Nan; CHEN-HUA LIU ; HUNG-CHIH YANG ; TUNG-HUNG SU ; TAI-CHUNG TSENG ; PEI-JER CHEN ; JIA-HORNG KAO ; CHUN-JEN LIU Journal of the Formosan Medical Association = Taiwan yi zhi811
252022Serum PIVKA-II and alpha-fetoprotein at virological remission predicts hepatocellular carcinoma in chronic hepatitis B related cirrhosisTUNG-HUNG SU ; Peng, Cheng-Yuan; Chang, Shan-Han; TAI-CHUNG TSENG ; CHUN-JEN LIU ; CHI-LING CHEN ; CHEN-HUA LIU ; HUNG-CHIH YANG ; PEI-JER CHEN ; JIA-HORNG KAO Journal of the Formosan Medical Association = Taiwan yi zhi1110
262022Hepatitis C virus reinfection in patients on haemodialysis after achieving sustained virologic response with antiviral treatmentCHEN-HUA LIU ; Peng, Cheng-Yuan; Kao, Wei-Yu; Yang, Sheng-Shun; Shih, Yu-Lueng; CHIH-YUAN LEE ; MENG-KUN TSAI ; Lee, Chih-Yuan; Chang, Chun-Chao; Wu, Jo-Hsuan; CHUN-JEN LIU ; TUNG-HUNG SU ; TAI-CHUNG TSENG ; PEI-JER CHEN ; JIA-HORNG KAO Alimentary pharmacology & therapeutics119
272022Pan-genotypic direct-acting antivirals for patients with hepatitis C virus infection and chronic kidney disease stage 4 or 5CHEN-HUA LIU ; JIA-HORNG KAO Hepatology International78
282022Sofosbuvir-based direct-acting antivirals for patients with decompensated hepatitis C virus-related cirrhosisCHEN-HUA LIU ; CHUN-JEN LIU ; JIA-HORNG KAO Journal of the Chinese Medical Association : JCMA00
292022Treatment outcomes of sofosbuvir/velpatasvir/voxilaprevir among NS5A inhibitor-experienced patients with hepatitis C: Real-world data from a multicenter Asian registryWong Y.J.; Kumar R.; Kumar R.; Tan J.; CHEN-HUA LIU ; Hui V.W.-K.; Tan S.S.; JIA-HORNG KAO ; Wong G.L.-H.; Thurairajah P.H.Journal of Gastroenterology and Hepatology (Australia)42
302022Impact of Sofosbuvir-Based Direct-Acting Antivirals on Renal Function in Chronic Hepatitis C Patients With Impaired Renal Function: A Large Cohort Study From the Nationwide HCV Registry Program (TACR)Huang C.-F.; Tseng K.-C.; Cheng P.-N.; Hung C.-H.; Lo C.-C.; Peng C.-Y.; Bair M.-J.; Yeh M.-L.; Chen C.-H.; Lee P.-L.; Lin C.-Y.; Kuo H.-T.; Chen C.-T.; Yang C.-C.; Huang J.-F.; Tai C.-M.; Hu J.-T.; Lin C.-L.; Su W.-W.; Tsai W.-L.; Huang Y.-H.; Cheng C.-Y.; Lin C.-L.; Wang C.-C.; Yang S.-S.; Mo L.-R.; Chen G.-Y.; Chang C.-C.; Wang S.-J.; Huang C.-S.; Hsieh T.-Y.; Lin C.-W.; Lee T.-H.; Chong L.-W.; Huang C.-W.; Chang S.-N.; Tsai M.-C.; SHIH-JER HSU ; JIA-HORNG KAO ; CHUN-JEN LIU ; CHEN-HUA LIU ; Lin H.-C.; Lee M.-H.; Tsai P.-C.; Dai C.-Y.; Chuang W.-L.; Chen C.-Y.; Yu M.-L.Clinical Gastroenterology and Hepatology1412
312022Ledipasvir/sofosbuvir for HCV genotype 1, 2, 4–6 infection: Real-world evidence from a nationwide registry in TaiwanLo C.-C.; Huang C.-F.; Cheng P.-N.; Tseng K.-C.; Chen C.-Y.; Kuo H.-T.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; Chen C.-H.; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Chang T.S.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Chen C.-T.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Lin C.-L.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Mo L.-R.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Hsiung C.-K.; Kao C.-N.; Tsai P.-C.; CHEN-HUA LIU ; Lee M.-H.; CHUN-JEN LIU ; Dai C.-Y.; Chuang W.-L.; Lin H.-C.; JIA-HORNG KAO ; Yu M.-L.; TACR investigatorsJournal of the Formosan Medical Association30
322022Factors Associated with Significant Platelet Count Improvement in Thrombocytopenic Chronic Hepatitis C Patients Receiving Direct-Acting AntiviralsChen Y.-C.; Chang T.-S.; Chen C.-H.; Cheng P.-N.; Lo C.-C.; Mo L.-R.; Chen C.-T.; Huang C.-F.; Kuo H.-T.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Lin C.-L.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Hsiung C.-K.; Kao C.-N.; Tsai P.-C.; CHEN-HUA LIU ; Lee M.-H.; Dai C.-Y.; JIA-HORNG KAO ; Chuang W.-L.; Lin H.-C.; Chen C.-Y.; Tseng K.-C.; Yu M.-L.; on behalf of TACR investigatorsViruses11
332022Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in TaiwanCheng P.-N.; Mo L.-R.; Chen C.-T.; Chen C.-Y.; Huang C.-F.; Kuo H.-T.; Lo C.-C.; Tseng K.-C.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; Chen C.-H.; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Chang T.S.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Lin C.-L.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Chou K.-H.; Kao C.-N.; Tsai P.-C.; CHEN-HUA LIU ; Lee M.-H.; Cheng C.-Y.; Tsai M.-C.; CHUN-JEN LIU ; Dai C.-Y.; Lin H.-C.; JIA-HORNG KAO ; Chuang W.-L.; Yu M.-L.; TACR investigatorsInfectious Diseases and Therapy98
342021Ledipasvir/Sofosbuvir for 8, 12, or 24 Weeks in Hepatitis C Patients Undergoing Dialysis for End-Stage Renal DiseaseChuang W.-L.; Hu T.-H.; Buggisch P.; Moreno C.; Su W.-W.; Biancone L.; Camargo M.; Hyland R.; Lu S.; Kirby B.J.; Dvory-Sobol H.; Osinusi A.; Gaggar A.; Peng C.-Y.; CHEN-HUA LIU ; Sise M.E.; Mangia A.The American journal of gastroenterology76
352021Sofosbuvir/velpatasvir plus ribavirin for child-pugh b and child-pugh c hepatitis c virus-related cirrhosisCHEN-HUA LIU ; Chen C.-Y.; Su W.-W.; CHUN-JEN LIU ; Lo C.-C.; Huang K.-J.; Chen J.-J.; Tseng K.-C.; Chang C.-Y.; Peng C.-Y.; Shih Y.-L.; Huang C.-S.; Kao W.-Y.; Yang S.-S.; Tsai M.-C.; Wu J.-H.; Chen P.-Y.; Su P.-Y.; Hwang J.-J.; YU-JEN FANG ; Lee P.-L.; Tseng C.-W.; Lee F.-J.; Lai H.-C.; Hsieh T.-Y.; Chang C.-C.; Chang C.-H.; Huang Y.-J.; JIA-HORNG KAO Clinical and Molecular Hepatology88
362021Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral loadTAI-CHUNG TSENG ; CHUN-JEN LIU ; Yang W.-T; Hsu C.-Y; CHUN-MING HONG ; TUNG-HUNG SU ; Tsai C.-H; CHI-LING CHEN ; HUNG-CHIH YANG ; CHEN-HUA LIU ; Chen, Tony Hsiu Hsi ; PEI-JER CHEN ; JIA-HORNG KAO Alimentary Pharmacology and Therapeutics1415
372021Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis-related complications (Taiwanese chronic hepatitis C cohort)Hsu W.-F.; Tsai P.-C.; Chen C.-Y.; Tseng K.-C.; Lai H.-C.; Kuo H.-T.; Hung C.-H.; Tung S.-Y.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Lin C.-Y.; Yang C.-C.; Lo G.-H.; Tai C.-M.; Lin C.-W.; JIA-HORNG KAO ; CHUN-JEN LIU ; CHEN-HUA LIU ; Yan S.-L.; Bair M.-J.; Su W.-W.; Chu C.-H.; Chen C.-J.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Huang J.-F.; Dai C.-Y.; Chuang W.-L.; Yu M.-L.; Peng C.-Y.Journal of Gastroenterology and Hepatology (Australia)710
382021Long-term outcome of liver complications in patients with chronic HBV/HCV co-infection after antiviral therapy: a real-world nationwide study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)Yeh M.-L.; Hung C.-H.; Tseng K.-C.; Lai H.-C.; Chen C.-Y.; Kuo H.-T.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Yang C.-C.; Lo G.-H.; Tai C.-M.; Lin C.-W.; JIA-HORNG KAO ; CHEN-HUA LIU ; Yan S.-L.; Bair M.-J.; Lin C.-Y.; Su W.-W.; Chu C.-H.; Chen C.-J.; Tung S.-Y.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Huang C.-F.; Huang J.-F.; Dai C.-Y.; Chuang W.-L.; Tsai P.-C.; Peng C.-Y.; CHUN-JEN LIU ; Yu M.-L.Hepatology International45
392021Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in TaiwanCHEN-HUA LIU ; Chen P.-Y.; Chen J.-J.; Lo C.-C.; Su W.-W.; Tseng K.-C.; CHUN-JEN LIU ; Huang C.-S.; Huang K.-J.; Yang S.-S.; Peng C.-Y.; Tsai M.-C.; Kao W.-Y.; Chang C.-Y.; Shih Y.-L.; YU-JEN FANG ; Chen C.-Y.; Lee P.-L.; Huang J.-J.; Su P.-Y.; Tseng C.-W.; CHIEN-CHING HUNG ; Chang C.-H.; Huang Y.-J.; Lai H.-C.; Chang C.-C.; Lee F.-J.; Hsieh T. Y.; JIA-HORNG KAO Hepatology International1414
402021Last Mile to Microelimination of Hepatitis C Virus Infection Among People Living With Human Immunodeficiency VirusCHEN-HUA LIU ; JIA-HORNG KAO Clinical infectious diseases : an official publication of the Infectious Diseases Society of America76
412021Reply to: “Sofosbuvir and the risk of kidney dysfunction”CHEN-HUA LIU ; JIA-HORNG KAO Journal of Hepatology00
422021Factors associated with treatment failure of direct-acting antivirals for chronic hepatitis C: A real-world nationwide hepatitis C virus registry programme in TaiwanChen C.-Y.; Huang C.-F.; Cheng P.-N.; Tseng K.-C.; Lo C.-C.; Kuo H.-T.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; Chen C.-H.; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Chen C.-T.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Lin C.-L.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Mo L.-R.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Hsiung C.-K.; Kao C.-N.; Tsai P.-C.; CHEN-HUA LIU ; Lee M.-H.; CHUN-JEN LIU ; Dai C.-Y.; JIA-HORNG KAO ; Chuang W.-L.; Lin H.-C.; Yu M.-L.Liver International2523
432021Evolution of estimated glomerular filtration rate in human immunodeficiency virus and hepatitis C virus-coinfected patients receiving sofosbuvir-based direct-acting antivirals and antiretroviral therapyCHEN-HUA LIU ; HSIN-YUN SUN ; SZU-MIN HSIEH ; Liu W.-C.; WANG-HUEI SHENG ; CHUN-JEN LIU ; TUNG-HUNG SU ; TAI-CHUNG TSENG ; PEI-JER CHEN ; CHIEN-CHING HUNG ; JIA-HORNG KAO Journal of Viral Hepatitis66
442021Long-term risk of end-stage renal diseases with maintenance dialysis among chronic hepatitis C patients after antiviral therapy in TaiwanHsieh M.-H.; Bair M.-J.; Tsai P.-C.; Tseng K.-C.; Lo C.-C.; Chen C.-Y.; Kuo H.-T.; Hung C.-H.; Lai H.-C.; Peng C.-Y.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Yang C.-C.; Lo G.-H.; JIA-HORNG KAO ; CHUN-JEN LIU ; CHEN-HUA LIU ; Yan S.-L.; Lin C.-Y.; Su W.-W.; Chu C.-H.; Chen C.-J.; Tung S.-Y.; Tai C.-M.; Lin C.-W.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Yeh M.-L.; Huang C.-F.; Huang J.-F.; Dai C.-Y.; Yu M.-L.; Chuang W.-L.; T-COACH investigatorsJournal of Gastroenterology and Hepatology (Australia)23
452020Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral TherapyTAI-CHUNG TSENG ; Peng C.-Y; Hsu Y.-C; TUNG-HUNG SU ; Wang C.-C; CHUN-JEN LIU ; HUNG-CHIH YANG ; Yang W.-T; Lin C.-H; Yu M.-L; Lai H.-C; Tanaka Y; Nguyen M.H; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO Liver Cancer1713
462020Successful antiviral therapy reduces risk of schizophrenia among chronic hepatitis c patients: A nationwide real-world Taiwanese cohort (T-COACH)Tsai P.-C.; Chen C.-Y.; Kuo H.-T.; Hung C.-H.; Tseng K.-C.; Lai H.-C.; Peng C.-Y.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Yang C.-C.; Lo G.-H.; JIA-HORNG KAO ; CHUN-JEN LIU ; CHEN-HUA LIU ; Yan S.-L.; Bair M.-J.; Lin C.-Y.; Su W.-W.; Chu C.-H.; Chen C.-J.; Tung S.-Y.; Tai C.-M.; Lin C.-W.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Yeh M.-L.; Huang C.-F.; Hsieh M.-H.; Huang J.-F.; Dai C.-Y.; Chung W.-L.; Ke C.-L.K.; Yu M.-L.; T-COACH Study GroupOpen Forum Infectious Diseases33
472020Sofosbuvir/velpatasvir/voxilaprevir plus ribavirin for chronic hepatitis C patients with direct acting antiviral failures: Implications for viral elimination in TaiwanCHEN-HUA LIU ; TUNG-HUNG SU ; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO Journal of the Formosan Medical Association44
482020HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosisTAI-CHUNG TSENG ; CHUN-JEN LIU ; Chang C.T; TUNG-HUNG SU ; Yang W.-T; Tsai C.-H; CHI-LING CHEN ; HUNG-CHIH YANG ; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO Journal of Hepatology4132
492020Hepatitis C virus cure rates are reduced in patients with active but not inactive hepatocellular carcinoma: A practice implicationOgawa E.; Toyoda H.; Iio E.; Jun D.W.; Huang C.-F.; Enomoto M.; Hsu Y.-C.; Haga H.; Iwane S.; Wong G.; Lee D.H.; Tada T.; CHEN-HUA LIU ; Chuang W.-L.; Hayashi J.; Cheung R.; Yasuda S.; Tseng C.-H.; Takahashi H.; Tran S.; Yeo Y.H.; Henry L.; Barnett S.D.; Nomura H.; Nakamuta M.; Dai C.-Y.; Huang J.-F.; Yang H.-I.; Lee M.-H.; Jun M.J.; JIA-HORNG KAO ; Eguchi Y.; Ueno Y.; Tamori A.; Furusyo N.; Yu M.-L.; Tanaka Y.; Nguyen M.H.; Ahn S.B.; Azuma K.; Dohmen K.; Jeong J.Y.; Jung J.H.; Kajiwara E.; Kato M.; Kawano A.; Koyanagi T.; Ooho A.; Park S.H.; Satoh T.; Shimoda S.; Song D.S.; Takahashi K.; Yeh M.-L.; Yoon E.L.; Real-World Evidence from the Asia Liver Consortium InvestigatorsClinical Infectious Diseases2619
502020Sustained virological response to hepatitis C therapy does not decrease the incidence of systemic lupus erythematosus or rheumatoid arthritisHsu W.-F.; Chen C.-Y.; Tseng K.-C.; Lai H.-C.; Kuo H.-T.; Hung C.-H.; Tung S.-Y.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Lin C.-Y.; Yang C.-C.; Lo G.-H.; Tai C.-M.; Lin C.-W.; JIA-HORNG KAO ; CHUN-JEN LIU ; CHEN-HUA LIU ; Yan S.-L.; Bair M.-J.; Su W.-W.; Chu C.-H.; Chen C.-J.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Tsai P.-C.; Huang J.-F.; Dai C.-Y.; Chuang W.-L.; Yu M.-L.; Peng C.-Y.Scientific Reports44
512020High risk of clinical relapse in patients with chronic Hepatitis B virus infection after cessation of prophylactic antiviral therapy for rituximab-containing chemotherapyChang W.-Y.; Chiu Y.-C; Chiu F.-W; Hsu Y.-C; TAI-CHUNG TSENG ; Cheng P.-N; Yang S.-S; CHUN-JEN LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO Journal of Infectious Diseases55
522020Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in TaiwanCHEN-HUA LIU ; CHUN-JEN LIU ; CHIEN-CHING HUNG ; SZU-MIN HSIEH ; TUNG-HUNG SU ; HSIN-YUN SUN ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO Liver International2120
532020Extrahepatic Malignancy Among Patients With Chronic Hepatitis C After Antiviral Therapy: A Real-World Nationwide Study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)Huang C.-F.; Lai H.-C.; Chen C.-Y.; Tseng K.-C.; Kuo H.-T.; Hung C.-H.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Yang C.-C.; Lo G.-H.; Tai C.-M.; Lin C.-W.; JIA-HORNG KAO ; CHUN-JEN LIU ; CHEN-HUA LIU ; Yan S.-L.; Bair M.-J.; Lin C.-Y.; Su W.-W.; Chu C.-H.; Chen C.-J.; Tung S.-Y.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Yeh M.-L.; Huang J.-F.; Dai C.-Y.; Chuang W.-L.; Tsai P.-C.; Peng C.-Y.; Yu M.-L.The American journal of gastroenterology2017
542020Evolution of eGFR in chronic HCV patients receiving sofosbuvir-based or sofosbuvir-free direct-acting antiviralsCHEN-HUA LIU ; Lee M.-H.; JOU-WEI LIN ; CHUN-JEN LIU ; TUNG-HUNG SU ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO Journal of Hepatology4143
552020Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysisCHEN-HUA LIU ; Peng C.-Y.; YU-JEN FANG ; Kao W.-Y.; Yang S.-S.; Lin C.-K.; Lai H.-C.; Su W.-P.; Fang S.-U.; Chang C.-C.; TUNG-HUNG SU ; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO Scientific Reports86
562020Serum Mac-2-Binding Protein Glycosylation Isomer at Virological Remission Predicts Hepatocellular Carcinoma and Death in Chronic Hepatitis B-Related CirrhosisTUNG-HUNG SU ; Peng C.-Y; TAI-CHUNG TSENG ; HUNG-CHIH YANG ; CHUN-JEN LIU ; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO Journal of Infectious Diseases108
5720202020 Taiwan consensus statement on the management of hepatitis C: part (I) general populationYu M.-L.; PEI-JER CHEN ; Dai C.-Y.; Hu T.-H.; Huang C.-F.; Huang Y.-H.; Hung C.-H.; Lin C.-Y.; CHEN-HUA LIU ; CHUN-JEN LIU ; Peng C.-Y.; Lin H.-C.; JIA-HORNG KAO ; Chuang W.-L.Journal of the Formosan Medical Association5751
582020Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairmentCHEN-HUA LIU ; Chen C.-Y.; Su W.-W.; Tseng K.-C.; Lo C.-C.; CHUN-JEN LIU ; Chen J.-J.; Peng C.-Y.; Shih Y.-L.; Yang S.-S.; Huang C.-S.; Huang K.-J.; Chang C.-Y.; Tsai M.-C.; Kao W.-Y.; YU-JEN FANG ; Chen P.-Y.; Su P.-Y.; Tseng C.-W.; Huang J.-J.; Lee P.-L.; Lai H.-C.; Hsieh T.-Y.; Chang C.-H.; Huang Y.-J.; Lee F.-J.; Chang C.-C.; JIA-HORNG KAO Gut2627
592020Use of glecaprevir/pibrentasvir in patients with chronic hepatitis c virus infection and severe renal impairmentYap D.Y.H.; Liu K.S.H.; Hsu Y.-C.; Wong G.L.H.; Tsai M.-C.; CHIEN-HUNG CHEN ; Hsu C.-S.; Hui Y.T.; Li M.K.K.; CHEN-HUA LIU ; Kan Y.-M.; Yu M.-L.; Yuen M.-F.Clinical and Molecular Hepatology78
602020Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world dataCHUN-MING HONG ; CHEN-HUA LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; PEI-JER CHEN ; Chen Y.-W; JIA-HORNG KAO ; CHUN-JEN LIU Journal of Microbiology, Immunology and Infection1718
6120202020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populationsYu M.-L.; PEI-JER CHEN ; Dai C.-Y.; Hu T.-H.; Huang C.-F.; Huang Y.-H.; Hung C.-H.; Lin C.-Y.; CHEN-HUA LIU ; CHUN-JEN LIU ; Peng C.-Y.; Lin H.-C.; JIA-HORNG KAO ; Chuang W.-L.Journal of the Formosan Medical Association5847
622020Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancerTUNG-HUNG SU ; TAI-CHUNG TSENG ; CHUN-JEN LIU ; Chou S.-W; CHEN-HUA LIU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; CHI-LING CHEN ; JIA-HORNG KAO International Journal of Cancer44
632020Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairmentCHEN-HUA LIU ; Yang S.-S.; Peng C.-Y.; Lin W.-T.; CHUN-JEN LIU ; TUNG-HUNG SU ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO Journal of Viral Hepatitis2020
642019HCV reinfections after viral clearance among HIV-positive patients with recent HCV infection in TaiwanHuang M.-H.; SUI-YUAN CHANG ; CHEN-HUA LIU ; ARISTINE CHENG ; Su L.-H.; Liu W.-C.; Su Y.-C.; HSIN-YUN SUN ; CHIEN-CHING HUNG ; SHAN-CHWEN CHANG Liver International2924
652019Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysisCHEN-HUA LIU ; Shih Y.-L; Yang S.-S; Lin C.-L; YU-JEN FANG ; Cheng P.-N; Chen C.-Y; Peng C.-Y; Hsieh T.-Y; Chiu Y.-C; TUNG-HUNG SU ; CHUN-JEN LIU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO Journal of Gastroenterology and Hepatology (Australia)77
662019Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of ParkinsonismTUNG-HUNG SU ; HUNG-CHIH YANG ; TAI-CHUNG TSENG ; Chou S.-W; CHIN-HSIEN LIN ; CHEN-HUA LIU ; CHUN-JEN LIU ; CHI-LING CHEN ; JIA-HORNG KAO Movement Disorders1414
672019Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myelomaTUNG-HUNG SU ; CHUN-JEN LIU ; TAI-CHUNG TSENG ; Chou S.-W; CHEN-HUA LIU ; HUNG-CHIH YANG ; SHANG-JU WU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHI-LING CHEN ; JIA-HORNG KAO Alimentary Pharmacology and Therapeutics2926
682019Real-world anti-viral treatment decisions among chronic hepatitis C patients in Taiwan: The INITIATE studyCHEN-HUA LIU ; Yu M.-L.; Peng C.-Y.; Hsieh T.-Y.; Huang Y.-H.; Su W.-W.; Cheng P.-N.; Lin C.-L.; Lo C.-C.; Chen C.-Y.; Chen J.-J.; Ma Q.; Brooks-Rooney C.; JIA-HORNG KAO Journal of the Formosan Medical Association88
692019Editorial: nephrotoxicity and oral anti-viral therapy for HBV-facts or fiction?CHEN-HUA LIU ; JIA-HORNG KAO Alimentary Pharmacology and Therapeutics11
702019Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infectionCHEN-HUA LIU ; TUNG-HUNG SU ; CHUN-JEN LIU ; CHUN-MING HONG ; HUNG-CHIH YANG ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO Journal of Gastroenterology and Hepatology (Australia)1415
712019Profile and value of FIB-4 in patients with dual chronic hepatitis C and BCHUN-JEN LIU ; TAI-CHUNG TSENG ; Yang W.-T; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO Journal of Gastroenterology and Hepatology (Australia)109
722019High Level of Hepatitis B Core–Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral LoadTAI-CHUNG TSENG ; CHUN-JEN LIU ; Hsu C.-Y; CHUN-MING HONG ; TUNG-HUNG SU ; Yang W.-T; CHI-LING CHEN ; HUNG-CHIH YANG ; Huang Y.-T; Fang-Tzu Kuo S; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO Gastroenterology9476
732019NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer stagingTUNG-HUNG SU ; SIH-HAN LIAO ; CHUN-MING HONG ; CHUN-JEN LIU ; TAI-CHUNG TSENG ; CHEN-HUA LIU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; CHI-LING CHEN ; Adhoute X; Bourlière M; JIA-HORNG KAO Journal of Gastroenterology and Hepatology (Australia)33
742019Editorial: comorbidities, concomitant medications and potential drug-drug interactions with interferon-free direct-acting anti-viral agents in chronic hepatitis C – authors’ replyCHEN-HUA LIU ; JIA-HORNG KAO Alimentary Pharmacology and Therapeutics00
752019Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutionsYu M.-L.; Hung C.-H.; Huang Y.-H.; Peng C.-Y.; Lin C.-Y.; Cheng P.-N.; Chien R.-N.; SHIH-JER HSU ; CHEN-HUA LIU ; Huang C.-F.; Su C.-W.; Huang J.-F.; CHUN-JEN LIU ; JIA-HORNG KAO ; Chuang W.-L.; PEI-JER CHEN ; DING-SHINN CHEN Journal of the Formosan Medical Association108
762019Direct-acting antivirals in East Asian hepatitis C patients: real-world experience from the REAL-C ConsortiumHuang C.-F.; Iio E.; Jun D.W.; Ogawa E.; Toyoda H.; Hsu Y.-C.; Haga H.; Iwane S.; Enomoto M.; Lee D.H.; Wong G.; CHEN-HUA LIU ; Tada T.; Chuang W.-L.; Cheung R.; Hayashi J.; Tseng C.-H.; Yasuda S.; Tran S.; Kam L.; Henry L.; Jeong J.Y.; Nomura H.; Park S.H.; Nakamuta M.; Huang J.-F.; Tai C.-M.; Lo G.-H.; Lee M.-H.; Yang H.-I.; JIA-HORNG KAO ; Tamori A.; Eguchi Y.; Ueno Y.; Furusyo N.; Tanaka Y.; Yu M.-L.; Nguyen M.H.; For the REAL-C InvestigatorsHepatology International3127
772019Letter: contraindicated drug-drug interactions before and after initiation of direct-acting anti-viral agents in chronic hepatitis C patients in Taiwan. Authors’ replyCHEN-HUA LIU ; JIA-HORNG KAO Alimentary Pharmacology and Therapeutics00
782019Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infectionTUNG-HUNG SU ; CHUN-JEN LIU ; TAI-CHUNG TSENG ; Chou S.-W; CHEN-HUA LIU ; HUNG-CHIH YANG ; SHANG-JU WU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHI-LING CHEN ; JIA-HORNG KAO Alimentary Pharmacology and Therapeutics109
792018Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfectionCHEN-HUA LIU ; HSIN-YUN SUN ; CHUN-JEN LIU ; WANG-HUEI SHENG ; SZU-MIN HSIEH ; Lo Y.-C; Liu W.-C; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHUN-MING HONG ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; CHIEN-CHING HUNG ; JIA-HORNG KAO Alimentary Pharmacology and Therapeutics2521
802018Acoustic radiation force impulse US imaging: Liver stiffness in patients with chronic hepatitis B with and without antiviral therapyTUNG-HUNG SU ; Liao C.-H; CHEN-HUA LIU ; KAI-WEN HUANG ; TAI-CHUNG TSENG ; HUNG-CHIH YANG ; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO Radiology1714
812018Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in TaiwanCHEN-HUA LIU ; CHUN-JEN LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHUN-MING HONG ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO Journal of Gastroenterology and Hepatology (Australia)2524
822018Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in TaiwanCHEN-HUA LIU ; CHUN-JEN LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHUN-MING HONG ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO PLoS ONE1110
832018Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational studyCHEN-HUA LIU ; Huang Y.-J; Yang S.-S; Chang C.-H; Yang S.-S; HSIN-YUN SUN ; CHUN-JEN LIU ; Liu W.-C; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHUN-MING HONG ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; CHIEN-CHING HUNG ; JIA-HORNG KAO Scientific Reports2523
842018Comorbidities, concomitant medications and potential drug-drug interactions with interferon-free direct-acting antiviral agents in hepatitis C patients in TaiwanCHEN-HUA LIU ; Yu M.-L.; Peng C.-Y.; Hsieh T.-Y.; Huang Y.-H.; Su W.-W.; Cheng P.-N.; Lin C.-L.; Lo C.-C.; Chen C.-Y.; Chen J.-J.; Ma Q.; Brooks-Rooney C.; JIA-HORNG KAO Alimentary Pharmacology and Therapeutics4141
852018A noninvasive diagnosis of hepatic fibrosis by BioFibroScore® in chronic hepatitis C patientsCHEN-HUA LIU ; CHUN-JEN LIU ; CHUN-MING HONG ; TUNG-HUNG SU ; HUNG-CHIH YANG ; Chen K.-M; Huang Y.-P; Yeh Y.-M; Tien H.-L; Liu Y.-C; JIA-HORNG KAO ; DING-SHINN CHEN ; PEI-JER CHEN Journal of Gastroenterology and Hepatology (Australia)1515
862018Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infectionTAI-CHUNG TSENG ; CHUN-JEN LIU ; TUNG-HUNG SU ; Yang W.-T; CHI-LING CHEN ; HUNG-CHIH YANG ; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO Alimentary Pharmacology and Therapeutics1918
872018Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients with Chronic Hepatitis C Virus InfectionCHEN-HUA LIU ; YIH-SHARNG CHEN ; SHOEI-SHEN WANG ; CHUN-JEN LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHUN-MING HONG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO Clinical Infectious Diseases2621
882018Distinct Relapse Rates and Risk Predictors after Discontinuing Tenofovir and Entecavir TherapyTUNG-HUNG SU ; HUNG-CHIH YANG ; TAI-CHUNG TSENG ; JYH-MING LIOU ; CHEN-HUA LIU ; CHI-LING CHEN ; PEI-JER CHEN ; DING-SHINN CHEN ; CHUN-JEN LIU ; JIA-HORNG KAO Journal of Infectious Diseases5752
892017Treatment of de novo hepatitis C virus-related fibrosing cholestatic hepatitis after orthotopic heart transplantation by ledipasvir and sofosbuvirCHEN-HUA LIU ; YIH-SHARNG CHEN ; SHOEI-SHEN WANG ; JIA-HORNG KAO Journal of the Formosan Medical Association46
902017Urgency to treat patients with chronic hepatitis C in AsiaJIA-HORNG KAO ; Ahn S.H.; Chien R.-N.; Cho M.; Chuang W.-L.; Jeong S.-H.; CHEN-HUA LIU ; Paik S.-W.Journal of Gastroenterology and Hepatology (Australia)1918
912017Hepatitis B virus reactivation in patients receiving interferon-free direct-acting antiviral agents for chronic hepatitis C virus infectionCHEN-HUA LIU ; CHUN-JEN LIU ; TUNG-HUNG SU ; YU-JEN FANG ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO Open Forum Infectious Diseases4239
922017Fibrosis-4 Index Helps Identify HBV Carriers with the Lowest Risk of Hepatocellular CarcinomaTAI-CHUNG TSENG ; CHUN-JEN LIU ; TUNG-HUNG SU ; Yang W.-T; CHI-LING CHEN ; HUNG-CHIH YANG ; Wang C.-C; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO American Journal of Gastroenterology4239
932017Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C PatientsLee M.-H.; Huang C.-F; Lai H.-C; Lin C.-Y; Dai C.-Y; CHUN-JEN LIU ; Wang J.-H; Huang J.-F; Su W.-P; HUNG-CHIH YANG ; Kee K.-M; Yeh M.-L; Chuang P.-H; SHIH-JER HSU ; Huang C.-I; JIA-HORNG KAO ; CHIEH-CHANG CHEN ; Chen S.-H; Jeng W.-J; Yang H.-I; Yuan Y; Lu S.-N; Sheen I.-S; CHEN-HUA LIU ; Peng C.-Y; Yu M.-L; Chuang W.-L; Chen C.-J.Scientific Reports1614
942017Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosisTUNG-HUNG SU ; Shiau C.-W; Jao P; Yang N.-J; Tai W.-T; CHUN-JEN LIU ; TAI-CHUNG TSENG ; HUNG-CHIH YANG ; CHEN-HUA LIU ; KAI-WEN HUANG ; Hu T.-C; Huang Y.-J; YAO-MING WU ; Chen L.-J; PEI-JER CHEN ; DING-SHINN CHEN ; Chen K.-F; JIA-HORNG KAO Scientific Reports1211
952016Hepatocellular carcinoma recurrence after interferon-free direct acting antiviral treatment for chronic hepatitis C virus infection: Fact or fiction?CHEN-HUA LIU ; JIA-HORNG KAO Translational Cancer Research23
962016Hepatitis C viral infection increases the risk of lymphoid-neoplasms: A population-based cohort studyTUNG-HUNG SU ; CHUN-JEN LIU ; TAI-CHUNG TSENG ; Chou S.-W; CHEN-HUA LIU ; HUNG-CHIH YANG ; SHANG-JU WU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHI-LING CHEN ; JIA-HORNG KAO Hepatology3531
972016Prevalence and clinical implications of IL28B genotypes in Taiwanese patients with chronic hepatitis CMah Y.-H.; CHEN-HUA LIU ; CHI-LING CHEN ; TAI-CHUNG TSENG ; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO Journal of the Formosan Medical Association67
982016Hepatitis B surface antigen loss and hepatocellular carcinoma development in patients with dual hepatitis B and C infectionYang W.-T.; Wu L.-W; TAI-CHUNG TSENG ; CHI-LING CHEN ; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHUN-JEN LIU ; JIA-HORNG KAO Medicine (United States)2015
992015Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naïve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized TrialCHEN-HUA LIU ; Huang, Chung-Feng; CHUN-JEN LIU ; Dai, Chia-Yen; Huang, Jee-Fu; JOU-WEI LIN ; Liang, Cheng-Chao; Yang, Sheng-Shun; CHIH-HUNG LIN ; TUNG-HUNG SU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; Chuang, Wan-Long; JIA-HORNG KAO ; Yu, Ming-LungScientific reports88
1002015Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trialCHEN-HUA LIU ; Huang, Chung-Feng; CHUN-JEN LIU ; Dai, Chia-Yen; Huang, Jee-Fu; JOU-WEI LIN ; Liang, Cheng-Chao; Yang, Sheng-Shun; Lin, Chih-Lin; TUNG-HUNG SU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; Chuang, Wan-Long; JIA-HORNG KAO ; Yu, Ming-LungScientific reports77
1012015Serum biomarkers predictive of significant fibrosis and cirrhosis in chronic hepatitis BLin C.-L.; CHEN-HUA LIU ; Wang C.-C.; Liang C.-C.; TUNG-HUNG SU ; CHUN-JEN LIU ; JIA-HORNG KAO Journal of Clinical Gastroenterology3132
1022015Micro-evolution of the hepatitis B virus genome in hepatitis B e-antigen-positive carriers: Comparison of genotypes B and C at various immune stagesCHUN-JEN LIU ; Chen T.-C.; PEI-JER CHEN ; HURNG-YI WANG ; TAI-CHUNG TSENG ; Cheng H.-R.; CHEN-HUA LIU ; DING-SHINN CHEN ; JIA-HORNG KAO Journal of Gastroenterology and Hepatology (Australia)11
1032015Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapyLiang C.-C.; CHEN-HUA LIU ; Chung C.-S; Lin C.-K; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO Journal of Infectious Diseases76
1042015The synthesis of TiC/TiNi powders and bulk materialsYang R.S.; Fu Q.S.; Li M.T.; CHEN-HUA LIU ; Lin X.Z.; Chen J.Materials Research Innovations10
1052015Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infectionCheng H.-R.; JIA-HORNG KAO ; Wu H.-L; TAI-CHUNG TSENG ; CHEN-HUA LIU ; HUNG-CHIH YANG ; TUNG-HUNG SU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHUN-JEN LIU Hepatology International1411
1062015Comparison of abbott realtime HCV genotype II with versant line probe assay 2.0 for hepatitis C virus genotypingCHEN-HUA LIU ; Liang C.-C; CHUN-JEN LIU ; Lin C.-L; TUNG-HUNG SU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO Journal of Clinical Microbiology5855
1072015Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infectionTAI-CHUNG TSENG ; CHUN-JEN LIU ; CHI-LING CHEN ; Yang W.-T; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO Alimentary Pharmacology and Therapeutics4843
1082015Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patientsWang C.-C.; CHEN-HUA LIU ; Lin C.-L.; Wang P.-C.; TAI-CHUNG TSENG ; Lin H.H.; JIA-HORNG KAO Journal of the Formosan Medical Association2727
1092015Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibitionTUNG-HUNG SU ; Shiau C.-W; Jao P; CHEN-HUA LIU ; CHUN-JEN LIU ; Tai W.-T; YUNG-MING JENG ; HUNG-CHIH YANG ; TAI-CHUNG TSENG ; HSIANG-PO HUANG ; Cheng H.-R; PEI-JER CHEN ; Chen K.-F; JIA-HORNG KAO ; DING-SHINN CHEN Proceedings of the National Academy of Sciences of the United States of America6562
1102015Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naive Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort StudyCHEN-HUA LIU ; WANG-HUEI SHENG ; HSIN-YUN SUN ; SZU-MIN HSIEH ; Lo Y.-C; CHUN-JEN LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; Liu W.-C; PEI-JER CHEN ; DING-SHINN CHEN ; CHIEN-CHING HUNG ; JIA-HORNG KAO Scientific Reports1312
1112015Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trialCHEN-HUA LIU ; CHUN-JEN LIU ; Huang C.-F; JOU-WEI LIN ; Dai C.-Y; Liang C.-C; Huang J.-F; Hung P.-H; Tsai H.-B; MENG-KUN TSAI ; CHIH-YUAN LEE ; Chen S.-I; Yang S.-S; TUNG-HUNG SU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; Chuang W.-L; Yu M.-L; JIA-HORNG KAO Gut3630
1122015Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriersTAI-CHUNG TSENG ; CHUN-JEN LIU ; HUNG-CHIH YANG ; CHI-LING CHEN ; Yang W.-T; Tsai C.-S; Kuo S.F.-T; Verbree F.C; TUNG-HUNG SU ; Wang C.-C; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO Gut9884
1132014Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconvertersTAI-CHUNG TSENG ; CHUN-JEN LIU ; Yang W.-T; CHI-LING CHEN ; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO Journal of Gastroenterology and Hepatology (Australia)139
1142014Nanomedicines in the treatment of hepatitis C virus infection in Asian patients: Optimizing use of peginterferon alfaCHEN-HUA LIU ; JIA-HORNG KAO International Journal of Nanomedicine3334
1152014Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneouslyCheng H.-R.; JIA-HORNG KAO ; Wu H.-L.; Chen T.-C.; TAI-CHUNG TSENG ; CHEN-HUA LIU ; TUNG-HUNG SU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHUN-JEN LIU Liver International1311
1162014Serum cytokine/chemokine profiles in acute exacerbation of chronic hepatitis B: Clinical and mechanistic implicationsWu H.-L.; JIA-HORNG KAO ; Chen T.-C; Wu W.-H; CHEN-HUA LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; DING-SHINN CHEN ; PEI-JER CHEN ; CHUN-JEN LIU Journal of Gastroenterology and Hepatology (Australia)2824
1172014Triple therapy for hepatitis C virus infection in patients receiving hemodialysisCHEN-HUA LIU ; JIA-HORNG KAO Annals of Internal Medicine11
1182014Value of interleukin-28B genetic polymorphism on retreatment outcomes of chronic hepatitis C genotype 1 relapsers by peginterferon alfa plus ribavirinChen M.-Y.; CHEN-HUA LIU ; Chen T.-C.; TUNG-HUNG SU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO ; CHUN-JEN LIU Journal of Gastroenterology and Hepatology (Australia)87
1192014Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapyTUNG-HUNG SU ; CHUN-JEN LIU ; HUNG-CHIH YANG ; YUNG-MING JENG ; Cheng H.-R; CHEN-HUA LIU ; TAI-CHUNG TSENG ; THAI-YEN LING ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO Journal of Gastroenterology1614
1202013Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trialCHEN-HUA LIU ; Huang, Chung-Feng; CHUN-JEN LIU ; Dai, Chia-Yen; Liang, Cheng-Chao; Huang, Jee-Fu; Hung, Peir-Haur; HUNG-BIN TSAI ; MENG-KUN TSAI ; Chen, Shih-I; JOU-WEI LIN ; Yang, Sheng-Shun; TUNG-HUNG SU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; Chuang, Wan-Long; Yu, Ming-Lung; JIA-HORNG KAO Annals of internal medicine8577
1212013Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-upYu M.-L.; Lee C.-M; CHI-LING CHEN ; Chuang W.-L; Lu S.-N; CHEN-HUA LIU ; Wu S.-S; Liao L.-Y; Kuo H.-T; Chao Y.-C; Tung S.-Y; Yang S.-S; JIA-HORNG KAO ; Su W.-W; Lin C.-L; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; CHUN-JEN LIU Hepatology6559
1222013Association of IL28B genotypes with metabolic profiles and viral clearance rate in chronic hepatitis C patientsHsu C.-S.; SHIH-JER HSU ; Chen H.-C.; CHEN-HUA LIU ; Jeng J.; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO Hepatology International55
1232013Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkersTAI-CHUNG TSENG ; CHUN-JEN LIU ; CHI-LING CHEN ; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; Yang W.-T; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO Journal of Infectious Diseases4544
1242013Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis CTUNG-HUNG SU ; CHEN-HUA LIU ; CHUN-JEN LIU ; CHI-LING CHEN ; Ting T.-T.; TAI-CHUNG TSENG ; PEI-JER CHEN ; JIA-HORNG KAO ; DING-SHINN CHEN Proceedings of the National Academy of Sciences of the United States of America5352
1252013IL28B genotype on HCV infection in AsiaCHEN-HUA LIU ; JIA-HORNG KAO Current Hepatitis Reports30
1262013The Use of Transient Elastography in Liver DiseaseCHEN-HUA LIU Journal of Medical Ultrasound00
1272013Profound week 4 interferon responsiveness is mandatory for hepatitis C genotype 1 patients with unfavorable IL-28B genotypeHuang C.-F.; Yu M.-L.; JIA-HORNG KAO ; TAI-CHUNG TSENG ; Yeh M.-L.; Huang J.-F.; Dai C.-Y.; Lin Z.-Y.; Chen S.-C.; Wang L.-Y.; Juo S.H.H.; Chuang W.-L.; CHEN-HUA LIU Journal of Clinical Virology1617
1282013Longitudinal Change of HBsAg in HBeAg-negative Patients with Genotype B or C InfectionTUNG-HUNG SU ; CHUN-JEN LIU ; TAI-CHUNG TSENG ; CHEN-HUA LIU ; HUNG-CHIH YANG ; CHI-LING CHEN ; PEI-JER CHEN ; JIA-HORNG KAO ; DING-SHINN CHEN PLoS ONE2116
1292013Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversionHUNG-CHIH YANG ; CHI-LING CHEN ; Shen Y.-C; Peng C.-Y; CHUN-JEN LIU ; TAI-CHUNG TSENG ; TUNG-HUNG SU ; Chuang W.-L; Yu M.-L; Dai C.-Y; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO Hepatology4337
1302013Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loadsTAI-CHUNG TSENG ; CHUN-JEN LIU ; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; CHI-LING CHEN ; Hsu C.-A; Fang-Tzu Kuo S; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO Hepatology219195
1312012Impact of hepatitis B virus infection on metabolic profiles and modifying factorsHsu C.-S.; CHEN-HUA LIU ; Wang C.-C.; TAI-CHUNG TSENG ; CHUN-JEN LIU ; CHI-LING CHEN ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO Journal of Viral Hepatitis6054
1322012Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral loadTAI-CHUNG TSENG ; CHUN-JEN LIU ; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; CHI-LING CHEN ; Fang-Tzu Kuo S; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO Hepatology129115
1332012Serum interleukin 6 level correlates with outcomes of acute exacerbation of chronic hepatitis BPan C.J.-H.; Wu H.-L.; Kuo S.F.-T.; JIA-HORNG KAO ; TAI-CHUNG TSENG ; CHEN-HUA LIU ; PEI-JER CHEN ; CHUN-JEN LIU ; DING-SHINN CHEN Hepatology International1715
1342012High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV loadTAI-CHUNG TSENG ; CHUN-JEN LIU ; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; CHI-LING CHEN ; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO Gastroenterology430381
1352012Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapyCHEN-HUA LIU ; Liang C.-C.; CHUN-JEN LIU ; TAI-CHUNG TSENG ; Lin C.-L.; Yang S.-S.; TUNG-HUNG SU ; SHIH-JER HSU ; JOU-WEI LIN ; Chen J.-H.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO Antiviral Therapy4039
1362012Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirinCHEN-HUA LIU ; Liang, Cheng-Chao; CHUN-JEN LIU ; TAI-CHUNG TSENG ; Lin, Chih-Lin; Yang, Sheng-Shun; TUNG-HUNG SU ; JOU-WEI LIN ; Chen, Jun-Herng; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO Antiviral therapy2122
1372012Revisiting the Stopping Rule for Hepatitis C Genotype 1 Patients Treated with Peginterferon Plus RibavirinYu M.-L.; CHEN-HUA LIU ; Huang C.-F.; TAI-CHUNG TSENG ; Huang J.-F.; Dai C.-Y.; Lin Z.-Y.; Chen S.-C.; Wang L.-Y.; Juo S.-H.H.; Chuang W.-L.; JIA-HORNG KAO PLoS ONE1918
1382012Association of hepatitis C virus infection and malnutrition-inflammation complex syndrome in maintenance hemodialysis patientsTsai H.-B.; PAU-CHUNG CHEN ; CHEN-HUA LIU ; Hung P.-H.; Chen M.-T.; CHIH-KANG CHIANG ; JIA-HORNG KAO ; KUAN-YU HUNG Nephrology Dialysis Transplantation1110
1392012Young chronic hepatitis b patients with nucleos(t)ide analogue-induced hepatitis b e antigen seroconversion have a higher risk of HBV reactivationTAI-CHUNG TSENG ; CHUN-JEN LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; Wang C.-C; CHI-LING CHEN ; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO Journal of Infectious Diseases4443
1402011Transient elastography to assess hepatic fibrosis in hemodialysis chronic hepatitis C patientsCHEN-HUA LIU ; Liang, Cheng-Chao; KAI-WEN HUANG ; CHUN-JEN LIU ; Chen, Shih-I; JOU-WEI LIN ; Hung, Peir-Haur; Tsai, Hung-Bin; Lai, Ming-Yang; PEI-JER CHEN ; Chen, Jun-Herng; DING-SHINN CHEN ; JIA-HORNG KAO Clinical journal of the American Society of Nephrology : CJASN7169
1412011Interleukin-28B genetic variations and response to interferon-based therapy: Asian perspectivesCHEN-HUA LIU ; JIA-HORNG KAO Journal of Gastroenterology and Hepatology (Australia)66
1422011Effects of hepatitis B virus precore and basal core promoter mutations on the expression of viral antigens: Genotype B vs CCHUN-JEN LIU ; Cheng H.-R.; Chen C.-L.; Chen T.-C.; TAI-CHUNG TSENG ; Wang Z.-L.; PEI-JER CHEN ; CHEN-HUA LIU ; DING-SHINN CHEN ; JIA-HORNG KAO Journal of Viral Hepatitis2019
1432011Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapyTAI-CHUNG TSENG ; Yu M.-L.; CHUN-JEN LIU ; Lin C.-L.; Huang Y.-W.; Hsu C.-S.; CHEN-HUA LIU ; Kuo S.F.-T.; Pan C.J.-H.; Yang S.-S.; Su C.-W.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO Antiviral Therapy7670
1442011HCV core gene polymorphisms correlate with liver fibrosis but not sustained virological response in patients with genotype 1 infectionSHIH-JER HSU ; Hsu C.-S.; CHEN-HUA LIU ; CHUN-JEN LIU ; CHI-LING CHEN ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO Antiviral Therapy65
1452011Serum p53 gene polymorphisms and severity of hepatitis B or C-related chronic liver diseases in TaiwanMah Y.-H.; Hsu C.-S.; CHEN-HUA LIU ; CHUN-JEN LIU ; Lai M.-Y.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO Hepatology International1210
1462011Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapyHsu C.-S.; SHIH-JER HSU ; Chen H.-C.; TAI-CHUNG TSENG ; CHEN-HUA LIU ; Niu W.-F.; Jeng J.; CHUN-JEN LIU ; Lai M.-Y.; PEI-JER CHEN ; JIA-HORNG KAO ; DING-SHINN CHEN Proceedings of the National Academy of Sciences of the United States of America5654
1472011Treatment of hepatitis C virus infection in patients with end-stage renal diseaseCHEN-HUA LIU ; JIA-HORNG KAO Journal of Gastroenterology and Hepatology (Australia)6767
1482011Risk factors of hepatitis during Anti-tuberculous treatment and implications of hepatitis virus loadJANN-YUAN WANG ; CHEN-HUA LIU ; Hu F.-C.; Chang H.-C.; Liu J.-L.; JONG-MIN CHEN ; CHONG-JEN YU ; LI-NA LEE ; JIA-HORNG KAO ; PAN-CHYR YANG Journal of Infection6761
1492011Functional impairment of dendritic cells in patients infected with hepatitis C virus genotype 1 who failed peginterferon plus ribavirin therapyLiang C.-C.; CHEN-HUA LIU ; Lin Y.-L.; CHUN-JEN LIU ; BOR-LUEN CHIANG ; JIA-HORNG KAO Journal of Medical Virology107
1502010Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis BTUNG-HUNG SU ; Hsu C.-S.; CHI-LING CHEN ; CHEN-HUA LIU ; Huang Y.-W.; TAI-CHUNG TSENG ; CHUN-JEN LIU ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN ; JIA-HORNG KAO Antiviral Therapy7873
1512010The ratio of aminotransferase to platelets is a useful index for predicting hepatic fibrosis in hemodialysis patients with chronic hepatitis CCHEN-HUA LIU ; Liang C.-C.; CHUN-JEN LIU ; SHIH-JER HSU ; JOU-WEI LIN ; Chen S.-I.; Hung P.-H.; Tsai H.-B.; Lai M.-Y.; PEI-JER CHEN ; Chen J.-H.; DING-SHINN CHEN ; JIA-HORNG KAO Kidney International3132
1522010Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infectionHsu C.-S.; CHEN-HUA LIU ; CHUN-JEN LIU ; SHIH-JER HSU ; CHI-LING CHEN ; HWANG, JUEY-JEN ; Lai M.-Y.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO Journal of Gastroenterology and Hepatology (Australia)3030
1532010HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C virusesYu M.-L.; Lee C.-M.; Chuang W.-L.; Lu S.-N.; Dai C.-Y.; Huang J.-F.; Lin Z.-Y.; Hu T.-I.; Chen C.-H.; Hung C.-.; Wang J.-H.; CHI-LING CHEN ; JIA-HORNG KAO ; Lai M.-Y.; CHEN-HUA LIU ; TUNG-HUNG SU ; Wu S.-S.; Liao L.-Y.; Kuo H.-T.; Chao Y.-C.; Tung S.-Y.; Yang S.-S.; PEI-JER CHEN ; CHUN-JEN LIU ; DING-SHINN CHEN Journal of Infectious Diseases4237
1542010Pegylated interferon alfa-2a monotherapy for hemodialysis patients with acute hepatitis CCHEN-HUA LIU ; Liang C.-C.; CHUN-JEN LIU ; JOU-WEI LIN ; Chen S.-I.; Hung P.-H.; Tsai H.-B.; Lai M.-Y.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO Clinical Infectious Diseases3026
1552009Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C VirusesCHUN-JEN LIU ; Chuang W.; Lee C.; Yu M.; Lu S.; Wu S.; Liao L.; CHI-LING CHEN ; Kuo H.; Chao Y.; Tung S.; Yang S.; JIA-HORNG KAO ; CHEN-HUA LIU ; Su W.; Lin C.; YUNG-MING JENG ; PEI-JER CHEN ; DING-SHINN CHEN Gastroenterology182157
1562009Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infectionHsu C.-S.; CHEN-HUA LIU ; CHUN-JEN LIU ; Wang C.-C.; CHI-LING CHEN ; Lai M.-Y.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO American Journal of Gastroenterology3734
1572009Hepatitis B virus basal core promoter mutation and DNA load correlate with expression of hepatitis B core antigen in patients with chronic hepatitis BCHUN-JEN LIU ; YUNG-MING JENG ; CHI-LING CHEN ; Cheng H.-R.; PEI-JER CHEN ; Chen T.-C.; CHEN-HUA LIU ; Lai M.-Y.; DING-SHINN CHEN ; JIA-HORNG KAO Journal of Infectious Diseases2621
1582009High serum adiponectin correlates with advanced liver disease in patients with chronic hepatitis B virus infectionCHUN-JEN LIU ; PEI-JER CHEN ; Lai M.-Y.; CHEN-HUA LIU ; CHI-LING CHEN ; JIA-HORNG KAO ; DING-SHINN CHEN Hepatology International3229
1592009Pegylated interferon α-2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapyCHEN-HUA LIU ; Liang C.-C.; CHUN-JEN LIU ; Tsai H.-B.; Hung P.-H.; SHIH-JER HSU ; Chen S.-L.; JOU-WEI LIN ; Lai M.-Y.; Chen J.-H.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO Gut2623
1602009Factors affecting early viral load decline of Asian chronic hepatitis C patients receiving pegylated interferon plus ribavirin therapyHsu C.-S.; CHEN-HUA LIU ; CHUN-JEN LIU ; CHI-LING CHEN ; Lai M.-Y.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO Antiviral Therapy3330
1612008Pegylated interferon-α-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: A multicenter, randomized controlled trialCHEN-HUA LIU ; CHUN-JEN LIU ; Lin C.-L.; Liang C.-C.; SHIH-JER HSU ; Yang S.-S.; Hsu C.-S.; TAI-CHUNG TSENG ; Wang C.-C.; Lai M.-Y.; Chen J.-H.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO Clinical Infectious Diseases183170
1622008Thyrotoxic periodic paralysis induced by pegylated interferon alpha plus ribavirin for chronic hepatitis C [2]WEI-SHUN YANG ; Chu P.-L.; CHEN-HUA LIU ; Chung G.-B.; KWAN-DUN WU Journal of Clinical Gastroenterology10
1632008Pegylated interferon α-2a versus standard interferon α-2a for treatment-naïve dialysis patients with chronic hepatitis C: A randomised studyCHEN-HUA LIU ; Liang C.-C.; JOU-WEI LIN ; Chen S.-I.; Tsai H.-B.; Chang C.-S.; Hung P.-H.; JIA-HORNG KAO ; CHUN-JEN LIU ; Lai M.-Y.; Chen J.-H.; PEI-JER CHEN ; DING-SHINN CHEN Gut6761
1642008High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis CHsu C.-S.; CHUN-JEN LIU ; CHEN-HUA LIU ; Wang C.-C.; CHI-LING CHEN ; Lai M.-Y.; PEI-JER CHEN ; JIA-HORNG KAO ; DING-SHINN CHEN Liver International9591
1652008Esophageal varices: Noninvasive diagnosis with duplex doppler US in patients with compensated cirrhosisCHEN-HUA LIU ; SHIH-JER HSU ; Liang C.-C.; FENG-CHIAO TSAI ; JOU-WEI LIN ; CHUN-JEN LIU ; PEI-MING YANG ; Lai M.-Y.; PEI-JER CHEN ; Chen J.-H.; JIA-HORNG KAO ; DING-SHINN CHEN Radiology2724
1662008Metabolic profiles in patients with chronic hepatitis C: A case-control studyHsu C.-S.; CHUN-JEN LIU ; CHEN-HUA LIU ; CHI-LING CHEN ; Lai M.-Y.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO Hepatology International2728
1672007Noninvasive diagnosis of hepatic fibrosis in patients with chronic hepatitis C by splenic Doppler impedance indexCHEN-HUA LIU ; SHIH-JER HSU ; JOU-WEI LIN ; JUEY-JEN HWANG ; CHUN-JEN LIU ; PEI-MING YANG ; Lai, Ming-Yang; PEI-JER CHEN ; Chen, Jun-Herng; JIA-HORNG KAO ; DING-SHINN CHEN Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association2722
1682007Age is not a discriminating factor for outcomes of therapeutic upper gastrointestinal endoscopyTSUNG-CHUN LEE ; Huang S.-P.; Yang J.-Y.; Chang C.-Y.; JYH-MING LIOU ; CHEN-HUA LIU ; Huang M.-S.; HSIU-PO WANG Hepato-Gastroenterology910
1692007Interferon-based therapy for dialysis patients with chronic hepatitis C: Progress and challengesCHEN-HUA LIU ; CHUN-JEN LIU ; JIA-HORNG KAO Nephrology27
1702007Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV [6]CHEN-HUA LIU ; DING-SHINN CHEN ; JIA-HORNG KAO New England Journal of Medicine11
1712007Association of pre-S deletion mutant of hepatitis B virus with risk of hepatocellular carcinomaLin C.-L.; CHEN-HUA LIU ; Chen W.; Huang W.-L.; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN ; JIA-HORNG KAO Journal of Gastroenterology and Hepatology (Australia)7874
1722007Enterolith ileus in a patient with jejunal diverticulosis: Sonographic findingsCHEN-HUA LIU ; KAI-WEN HUANG ; Mo Y.-H.; PEI-MING YANG Journal of Clinical Ultrasound56
1732006Selective transmission of hepatitis C virus quasi species through a needlestick accident in acute resolving hepatitisCHEN-HUA LIU ; Chen, Bing-Fang; SHU-CHING CHEN ; Lai, Ming-Yang; JIA-HORNG KAO ; DING-SHINN CHEN Clinical Infectious Diseases1112
1742006Gastroduodenal corrosive injury after oral zinc oxideCHEN-HUA LIU ; Lee C.-T.; FENG-CHIAO TSAI ; SHIH-JER HSU ; PEI-MING YANG Annals of Emergency Medicine99
1752006Gastroduodenal corrosive injury after oral zinc oxide [4]CHEN-HUA LIU ; Lee C.-T.; FENG-CHIAO TSAI ; SHIH-JER HSU ; PEI-MING YANG Annals of Emergency Medicine10
1762006Splenic vein thrombosis and Klebsiella pneumoniae septicemia after endoscopic gastric variceal obturation therapy with N-butyl-2-cyanoacrylateCHEN-HUA LIU ; FENG-CHIAO TSAI ; PO-CHIN LIANG ; Lee, Cha-Ze ; PEI-MING YANG Gastrointestinal Endoscopy2219
1772006Noninvasive tests for the prediction of significant hepatic fibrosis in hepatitis C virus carriers with persistently normal alanine aminotransferasesCHEN-HUA LIU ; JOU-WEI LIN ; FENG-CHIAO TSAI ; PEI-MING YANG ; Lai M.-Y.; Chen J.-H.; JIA-HORNG KAO ; DING-SHINN CHEN Liver International5452
1782006Successful colonoscopic drainage of appendiceal pus in acute appendicitisCHEN-HUA LIU ; FENG-CHIAO TSAI ; SHIH-JER HSU ; PEI-MING YANG Gastrointestinal Endoscopy109
1792005Biliary hamartomas with delayed 99mTc-diisopropyl iminodiacetic acid clearanceCHEN-HUA LIU ; RUOH-FANG YEN ; KAO-LANG LIU ; YUNG-MING JENG ; Pan M.-H.; PEI-MING YANG Journal of Gastroenterology24
1802002Osteonecrosis of the femoral head in a human immunodeficiency virus type 1-infected patient with lipodystrophyYU-CHIEH TSAI ; CHEN-HUA LIU ; Liao C.-H.; Chen M.-Y.; CHIEN-CHING HUNG Journal of the Formosan Medical Association45